Reevaluation of clinical trials of antimicrobials from viewpoints of protocol-defined schedule

Medicine and Dentistry

• Clinical Trial 100%
• Antiinfective Agent 20%
• Diseases 10%
• Amaurosis 10%
• Hospital 10%
• Infection 5%
• Physical Disease by Body Function 5%
• Cephem Derivative 5%
• Age 5%
• Cephem 5%
• Drug 5%
• Chemotherapeutic Agent 5%
• Protocol Compliance 5%
• Laboratory 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiinfective Agent 20%
• Diseases 10%
• Blindness 10%
• Physical Disease by Body Function 5%
• Cephem 5%
• Drug 5%
• Cephem Derivative 5%
• Infection 5%